US5342628A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Drug diffusion polymer system and method
Assignee: Applied Medical Research Inc
•
Filing: 1990-10-11
•
Granted: 1994-08-30
•
Expires: 2010-10-11
Abstract
Abstract A drug diffusion polymer system for the sustained release of drugs includes a composition comprising a polymeric matrix containing a uniform dispersion of a matrix expander and a drug. The matrix expander and drug are each present in the form of solid particulate. Upon exposure to body fluid or water, the matrix expander swells to cause the ingress of fluid into the polymeric matrix for solubilizing and diffusing the drug. Devices may incorporate such drug diffusion compositions as a coating or as a primary material of construction. Such devices may be formed by molding the compositions at room or elevated temperatures depending on the polymer used.
Inventors
- 👤 George J. Picha
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 09:54
CPC Classifications
A; A61; A61L; A61L29/00; A61L29/14; A61L29/16; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2031; A61K9/2036; A61K9/205; A61K9/2059; A61L29/08; A61L29/085; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406; A61L2300/60; A61L2300/602
Claims Analysis
Total Claims: 34
Claim 1
Independent Claim
151 words
A composition for administering a drug continuously to an aqueous body environment during a prolonged period of time at a controlled rate comprising a solid drug and a matrix expander substantially homogeneously dispersed in a polymeric matrix, said matrix expander being substantially insoluble in water but sufficiently water swellable to cause the ingress of water within the polymer matrix for dissolving and diffusing said drug into said aqueous body environment, said polymeric matrix comprising a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusion along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 2
Dependent Claim
151 words
A composition for administering a drug continuously to an aqueous body environment during a prolonged period of time at a controlled rate comprising a solid drug and a matrix expander substantially homogeneously dispersed in a polymeric matrix, said matrix expander being substantially insoluble in water but sufficiently water swellable to cause the ingress of water within the polymer matrix for dissolving and diffusing said drug into said aqueous body environment, said polymeric matrix comprising a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusion along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 3
Dependent Claim
15 words
The composition of claim 1, wherein said matrix expander comprises a physiologically acceptable hydrophilic polymer.
Claim 4
Dependent Claim
20 words
The composition of claim 2, wherein said matrix expander is selected from the group consisting of polyvinylpyrrolidone and hydroxyethyl starch.
Claim 5
Dependent Claim
23 words
The composition of claim 3, wherein said polymeric matrix is formed of a material selected from the group consisting of silicone and polyurethane.
Claim 6
Dependent Claim
11 words
The composition of claim 4, wherein said drug is an antibiotic.
Claim 7
Dependent Claim
32 words
The composition of claim 5, wherein said composition comprises from about 5% to about 45% of said matrix expander based on the weight of said composition and the remainder comprises said drug.
Claim 8
Dependent Claim
32 words
The composition of claim 6, wherein said composition comprises from about 10% to about 25% of said matrix expander based on the weight of said composition and the remainder comprises said drug.
Claim 9
Dependent Claim
16 words
The composition of claim 5, wherein said composition comprises about 25% or less of said drug.
Claim 10
Dependent Claim
17 words
The composition of claim 8, wherein said composition is moldable at temperatures of up to 115° C.
Claim 11
Independent Claim
222 words
A method of making a device for the release of a drug to an aqueous body environment during a prolonged period of time at a controlled rate comprising selecting a polymeric matrix material which is substantially impermeable to water in the aqueous body environment, selecting a matrix expander which is substantially insoluble in water but sufficiently water swellable to cause the ingress of water within the matrix material upon exposure to the water of said aqueous body environment, providing the drug as a solid at room temperature and at the use temperature for dissolution by the water of the aqueous body environment, uniformly dispersing the drug and matrix expander in the polymeric material to form a homogeneous blend, molding and curing said homogeneous blend at an elevated temperature to form a device of the desired shape and construction, said polymeric material providing in said device a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusing along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 12
Independent Claim
222 words
A method of making a device for the release of a drug to an aqueous body environment during a prolonged period of time at a controlled rate comprising selecting a polymeric matrix material which is substantially impermeable to water in the aqueous body environment, selecting a matrix expander which is substantially insoluble in water but sufficiently water swellable to cause the ingress of water within the matrix material upon exposure to the water of said aqueous body environment, providing the drug as a solid at room temperature and at the use temperature for dissolution by the water of the aqueous body environment, uniformly dispersing the drug and matrix expander in the polymeric material to form a homogeneous blend, molding and curing said homogeneous blend at an elevated temperature to form a device of the desired shape and construction, said polymeric material providing in said device a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusing along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 13
Dependent Claim
21 words
The method of claim 10, wherein the step of molding and curing said homogeneous blend are performed in an inert atmosphere.
Claim 14
Dependent Claim
31 words
The method of claim 11, wherein the step of molding and curing said homogeneous blend is performed at a temperature greater than that resulting in drug oxidation in an air environment.
Claim 15
Dependent Claim
33 words
The method of claim 11, wherein the drug has a oxidation temperature and the step of molding and curing said homogeneous composition is performed at a temperature greater than said drug oxidation temperature.
Claim 16
Dependent Claim
32 words
The method of claim 10, wherein the step of dispersing the drug and matrix expander in the polymeric matrix material includes purging the mixture of oxygen by substitution of an inert atmosphere.
Claim 17
Dependent Claim
21 words
The method of claim 10, wherein the step of molding and curing said homogeneous blend is performed in an inert atmosphere.
Claim 18
Dependent Claim
40 words
The method of claim 10, wherein the step of molding and curing said homogeneous blend includes the use of an elevated temperature molding process selected from the group consisting of dip molding, blow molding, injection molding, compression molding and casting.
Claim 19
Independent Claim
160 words
A method of releasing a drug to an aqueous body environment during a prolonged period of time at a controlled rate comprising providing a polymeric matrix containing a homogeneous dispersion of the drug and a matrix expander, exposing said polymeric matrix to the body environment to swell said polymeric matrix and cause water to be imbibed into the matrix for contact with the drug, and solubilizing drug contacted by the imbibed water for diffusion into the aqueous body environment, said polymeric matrix comprising a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusing along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 20
Independent Claim
160 words
A method of releasing a drug to an aqueous body environment during a prolonged period of time at a controlled rate comprising providing a polymeric matrix containing a homogeneous dispersion of the drug and a matrix expander, exposing said polymeric matrix to the body environment to swell said polymeric matrix and cause water to be imbibed into the matrix for contact with the drug, and solubilizing drug contacted by the imbibed water for diffusion into the aqueous body environment, said polymeric matrix comprising a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusing along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 21
Dependent Claim
22 words
The method of claim 17, wherein said dispersion of matrix expander is progressively swollen in a direction extending into said polymeric matrix.
Claim 22
Dependent Claim
33 words
The method of claim 18, wherein said polymeric matrix and matrix expander are substantially insoluble in the water of the aqueous body environment, and said drug is substantially insoluble in said polymeric matrix.
Claim 23
Dependent Claim
36 words
The method of claim 19, wherein said polymeric matrix is sized and shaped so that said drug diffuses into said aqueous body environment for a continuous period of time equal to about at least two weeks.
Claim 24
Dependent Claim
170 words
A drug diffusion device for administering a drug continuously to an aqueous body environment during a prolonged period of time comprising a composition including a solid drug and a matrix expander substantially homogeneously dispersed in a polymeric matrix, said polymeric matrix being substantially impermeable to water, and said drug being soluble in water, said matrix expander being substantially insoluble in water but sufficiently water swellable to cause the ingress of water within the polymer matrix for dissolving and diffusing said drug into said aqueous body environment, said polymeric material providing in said device a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusing along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 25
Dependent Claim
170 words
A drug diffusion device for administering a drug continuously to an aqueous body environment during a prolonged period of time comprising a composition including a solid drug and a matrix expander substantially homogeneously dispersed in a polymeric matrix, said polymeric matrix being substantially impermeable to water, and said drug being soluble in water, said matrix expander being substantially insoluble in water but sufficiently water swellable to cause the ingress of water within the polymer matrix for dissolving and diffusing said drug into said aqueous body environment, said polymeric material providing in said device a polymerized or cured continuous phase which is sufficiently liquid impermeable and hydrophobic to assure that drug release is substantially regulated by said matrix expander swelling, said matrix expander being sufficiently water insoluble to provide drug diffusion without dissolution of said matrix expander sufficient to materially affect the rate of drug diffusion, and said drug diffusing along and/or through said matrix expander and into said body environment without forming interconnected voids or porosity in said polymeric matrix.
Claim 26
Dependent Claim
18 words
A device as set forth in claim 21, wherein said matrix expander comprises a physiologically acceptable hydrophilic polymer.
Claim 27
Dependent Claim
23 words
A device as set forth in claim 22, wherein said matrix expander is selected from the group consisting of polyvinylpyrrolidone and hydroxyethyl starch.
Claim 28
Dependent Claim
26 words
A device as set forth in claim 23, wherein said polymeric matrix is formed of a material selected from the group consisting of silicone and polyurethane.
Claim 29
Dependent Claim
21 words
A device as set forth in claim 24, wherein said composition is the primary construction material used to form said device.
Claim 30
Dependent Claim
18 words
A device as set forth in claim 24, wherein said composition is a coating applied to said device.
Claim 31
Dependent Claim
34 words
A device as set forth in claim 26, wherein said device is a catheter and said polymeric matrix is formed of silicone, said matrix expander is hydroxyethyl starch and said drug is an antibiotic.
Claim 32
Dependent Claim
46 words
A device as set forth in claim 21, wherein said device includes a drug diffusion surface adapted to be exposed to said body environment for diffusion of drug into the body environment, said drug diffusion surface including a resistance membrane for limiting initial drug diffusion rates.
Claim 33
Dependent Claim
21 words
A device as set forth in claim 28, wherein said resistance membrane comprises a thin layer of a physiologically acceptable polymer.
Claim 34
Dependent Claim
20 words
A device as set forth in claim 29, wherein said thin layer of polymer has matrix expander homogeneously dispersed therein.
References Cited (Backward Citations)
US4764380A
Cited
US4839177A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-08-29 | 1998-02-28 | 1998-08-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-08-29 | 2002-02-28 | 2002-08-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-08-29 | 2006-02-28 | 2006-08-30 | $7700.00 | Window Closed / Lapsed |